Table 1.
β2 | Y122•/β2 | Specific activitya | Wild-type activityb | Kda |
---|---|---|---|---|
nmol/min/mg | % | μm | ||
WT | 1.2 | 7000 | 100.0 | 0.18b |
E52A | 1.0 | 13.4c | 0.2 | 0.96 |
E52D | 1.2 | 10.2c | 0.2 | 2.33 |
E52Q | 1.1 | 8.6c | 0.1 | 0.12 |
F3Y122• | 0.7 | 686 | 9.8 | |
E52Q/F3Y122• | 0.9 | 5.8c | 0.1 | <4 nmd |
a Specific activity was determined by the radioactive assay (49) and Kd was determined by the competitive binding method (12). All data are representative of at least two independent experiments.
b Previously reported (12).
c The wild-type NrdB that co-purifies with mutants may cause the low activity.
d Upper limit for Kd of E52Q/F3Y122•.